Encorafenib T6487
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
LGX818 is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity.
CAS nr:
1269440-17-6
Purity:
98%
Molecular Weight:
540,01
SMILES:
C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=CC(=CC(=C3F)NS(=O)(=O)C)Cl)C(C)C)NC(=O)OC
Formula:
C22H27ClFN7O4S
Pathway:
MAPK
Target:
Raf
